Recent advances in c-Met-based dual inhibitors in the treatment of cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in c-Met-based dual inhibitors in the treatment of cancers

Published:2024-06 Issue: Volume:272 Page:116477
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Jin Fanqi,Lin Yihan,Yuan Weidong,Wu Shuang,Yang Min,Ding Shi,Liu Ju,Chen Ye

Funder

Shenyang Science and Technology Bureau

Publisher

Elsevier BV

Reference119 articles.

1. Cancer statistics, 2023, J. CA: canc;Siegel;J. Clin.,2023

2. Cancer statistics, 2022, J. CA: canc;Siegel;J. Clin.,2022

3. Non-small cell lung cancer: current treatment and future advances;Zappa;J. Transl Lung Cancer Res,2016

4. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives;Zhong;J. Signal Transduct Target Ther,2021

5. Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs;Zhang;J. Eur J Med Chem,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights;Bioorganic Chemistry;2024-12

2. Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents;Bioorganic Chemistry;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP